Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Oct;39(10):2258–2261. doi: 10.1128/aac.39.10.2258

Effect of a bacterial lipopolysaccharide on biliary excretion of a beta-lactam antibiotic, cefoperazone, in rats.

S Haghgoo 1, T Hasegawa 1, M Nadai 1, L Wang 1, T Nabeshima 1, N Kato 1
PMCID: PMC162926  PMID: 8619579

Abstract

Klebsiella pneumoniae O3 lipopolysaccharide (LPS) has been found to dramatically modify the pharmacokinetics of the beta-lactam antibiotic cefazolin in rats. This study investigated the effect of LPS on the biliary excretion of the beta-lactam antibiotic cefoperazone (CPZ) in rats. CPZ is known to be actively secreted into the bile by a carrier-mediated transport system. LPS (250 micrograms/kg of body weight) was infused for 20 to 30 min 2 h before an intravenous administration of CPZ (20 mg/kg). The pharmacokinetic parameters of CPZ were estimated by a noncompartment model. LPS induced a significant decrease in the systemic clearance (by approximately 50%) and an increase in the mean residence time of CPZ. Significant decreases were also seen in the bile flow rate and in the biliary recovery of unchanged CPZ in the LPS-treated rats. LPS tended to increase the proportion of urinary excretion of CPZ. LPS significantly decreased the biliary clearance (by approximately 55%) and renal clearance (by approximately 35%) of CPZ. However, no changes in the volume of distribution at steady state for CPZ were observed between the treatment groups. Our findings suggest that LPS induces changes in the pharmacokinetics of CPZ as a result of changes occurring in the biliary secretory system.

Full Text

The Full Text of this article is available as a PDF (213.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Durham S. K., Brouwer A., Barelds R. J., Horan M. A., Knook D. L. Comparative endotoxin-induced hepatic injury in young and aged rats. J Pathol. 1990 Dec;162(4):341–349. doi: 10.1002/path.1711620412. [DOI] [PubMed] [Google Scholar]
  2. Freudenberg M. A., Freudenberg N., Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol. 1982 Feb;63(1):56–65. [PMC free article] [PubMed] [Google Scholar]
  3. Freudenberg M. A., Kleine B., Galanos C. The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule. Rev Infect Dis. 1984 Jul-Aug;6(4):483–487. doi: 10.1093/clinids/6.4.483. [DOI] [PubMed] [Google Scholar]
  4. Hasegawa T., Nadai M., Wang L., Haghgoo S., Nabeshima T., Kato N. Influence of endotoxin and lipid A on the renal handling and accumulation of gentamicin in rats. Biol Pharm Bull. 1994 Dec;17(12):1651–1655. doi: 10.1248/bpb.17.1651. [DOI] [PubMed] [Google Scholar]
  5. Hasegawa T., Nadai M., Wang L., Takayama Y., Kato K., Nabeshima T., Kato N. Renal excretion of famotidine and role of adenosine in renal failure induced by bacterial lipopolysaccharide in rats. Drug Metab Dispos. 1994 Jan-Feb;22(1):8–13. [PubMed] [Google Scholar]
  6. Hasegawa T., Ohta M., Mori M., Nakashima I., Kato N. The Klebsiella O3 lipopolysaccharide isolated from culture fluid: structure of the polysaccharide moiety. Microbiol Immunol. 1983;27(8):683–694. doi: 10.1111/j.1348-0421.1983.tb00631.x. [DOI] [PubMed] [Google Scholar]
  7. Hasegawa T., Ohta M., Nakashima I., Kato N., Morikawa K., Harada T., Okuyama T. Structure of the polysaccharide moiety of the Klebsiella O3 lipopolysaccharide isolated from culture supernatant of decapsulated mutant (Klebsiella O3:K1-). Chem Pharm Bull (Tokyo) 1985 Jan;33(1):333–339. doi: 10.1248/cpb.33.333. [DOI] [PubMed] [Google Scholar]
  8. Hewett J. A., Roth R. A. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev. 1993 Dec;45(4):382–411. [PubMed] [Google Scholar]
  9. Hinshaw L. B., Reins D. A., Hill R. J. Response of isolated liver to endotoxin. Can J Physiol Pharmacol. 1966 Jul;44(4):529–541. doi: 10.1139/y66-068. [DOI] [PubMed] [Google Scholar]
  10. Hirata K., Kaneko A., Ogawa K., Hayasaka H., Onoé T. Effect of endotoxin on rat liver. Analysis of acid phosphatase isozymes in the liver of normal and endotoxin-treated rats. Lab Invest. 1980 Aug;43(2):165–171. [PubMed] [Google Scholar]
  11. Kitamura T., Jansen P., Hardenbrook C., Kamimoto Y., Gatmaitan Z., Arias I. M. Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci U S A. 1990 May;87(9):3557–3561. doi: 10.1073/pnas.87.9.3557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Klaassen C. D., Watkins J. B., 3rd Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev. 1984 Mar;36(1):1–67. [PubMed] [Google Scholar]
  13. Levy E., Ruebner B. H. Hepatic changes produced by a single dose of endotoxin in the mouse. Light microscopy and histochemistry. Am J Pathol. 1967 Aug;51(2):269–285. [PMC free article] [PubMed] [Google Scholar]
  14. Nadai M., Hasegawa T., Kato K., Wang L., Nabeshima T., Kato N. Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats. Antimicrob Agents Chemother. 1993 Sep;37(9):1781–1785. doi: 10.1128/aac.37.9.1781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nadai M., Hasegawa T., Kato K., Wang L., Nabeshima T., Kato N. Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats. J Pharm Pharmacol. 1993 Nov;45(11):971–974. doi: 10.1111/j.2042-7158.1993.tb05638.x. [DOI] [PubMed] [Google Scholar]
  16. Nadai M., Hasegawa T., Wang L., Tagaya O., Nabeshima T. Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats. Drug Metab Dispos. 1994 Jul-Aug;22(4):561–565. [PubMed] [Google Scholar]
  17. Nakashima E., Matsushita R., Takeda M., Nakanishi T., Ichimura F. Comparative pharmacokinetics of cefoperazone and cephradine in untreated streptozotocin diabetic rats. Drug Metab Dispos. 1992 Sep-Oct;20(5):730–735. [PubMed] [Google Scholar]
  18. Neu H. C. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic. Ther Drug Monit. 1981;3(2):121–128. doi: 10.1097/00007691-198102000-00002. [DOI] [PubMed] [Google Scholar]
  19. Nolan J. P., O'Connell C. J. Vascular response in the isolated rat liver. I. Endotoxin, direct effects. J Exp Med. 1965 Dec 1;122(6):1063–1073. doi: 10.1084/jem.122.6.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ohta M., Mori M., Hasegawa T., Nagase F., Nakashima I., Naito S., Kato N. Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant. Microbiol Immunol. 1981;25(9):939–948. doi: 10.1111/j.1348-0421.1981.tb00098.x. [DOI] [PubMed] [Google Scholar]
  21. Praaning-van Dalen D. P., Brouwer A., Knook D. L. Clearance capacity of rat liver Kupffer, Endothelial, and parenchymal cells. Gastroenterology. 1981 Dec;81(6):1036–1044. [PubMed] [Google Scholar]
  22. Ruiter D. J., van der Meulen J., Brouwer A., Hummel M. J., Mauw B. J., van der Ploeg J. C., Wisse E. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest. 1981 Jul;45(1):38–45. [PubMed] [Google Scholar]
  23. Sathirakul K., Suzuki H., Yasuda K., Hanano M., Tagaya O., Horie T., Sugiyama Y. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. J Pharmacol Exp Ther. 1993 Jun;265(3):1301–1312. [PubMed] [Google Scholar]
  24. Tamai I., Maekawa T., Tsuji A. Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles. J Pharmacol Exp Ther. 1990 May;253(2):537–544. [PubMed] [Google Scholar]
  25. Tsuji A., Terasaki T., Imaeda N., Nishide K., Nakashima E. Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age. J Pharmacobiodyn. 1985 Mar;8(3):167–174. doi: 10.1248/bpb1978.8.167. [DOI] [PubMed] [Google Scholar]
  26. Tsuji A., Terasaki T., Takanosu K., Tamai I., Nakashima E. Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Evidence for a carrier-mediated transport system. Biochem Pharmacol. 1986 Jan 15;35(2):151–158. doi: 10.1016/0006-2952(86)90508-3. [DOI] [PubMed] [Google Scholar]
  27. Tsuji A., Yoshikawa T., Nishide K., Minami H., Kimura M., Nakashima E., Terasaki T., Miyamoto E., Nightingale C. H., Yamana T. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats. J Pharm Sci. 1983 Nov;72(11):1239–1252. doi: 10.1002/jps.2600721103. [DOI] [PubMed] [Google Scholar]
  28. Utili R., Abernathy C. O., Zimmerman H. J. Cholestatic effects of Escherichia coli endotoxin endotoxin on the isolated perfused rat liver. Gastroenterology. 1976 Feb;70(2):248–253. [PubMed] [Google Scholar]
  29. Utili R., Abernathy C. O., Zimmerman H. J. Endotoxin effects on the liver. Life Sci. 1977 Feb 15;20(4):553–568. doi: 10.1016/0024-3205(77)90458-1. [DOI] [PubMed] [Google Scholar]
  30. Utili R., Abernathy C. O., Zimmerman H. J. Inhibition of Na+, K+-adenosinetriphosphatase by endotoxin: a possible mechanism for endotoxin-induced cholestasis. J Infect Dis. 1977 Oct;136(4):583–587. doi: 10.1093/infdis/136.4.583. [DOI] [PubMed] [Google Scholar]
  31. Utili R., Abernathy C. O., Zimmerman H. J. Studies on the effects of C. coli endotoxin on canalicular bile formation in the isolated perfused rat liver. J Lab Clin Med. 1977 Mar;89(3):471–482. [PubMed] [Google Scholar]
  32. Van Bossuyt H., De Zanger R. B., Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J Hepatol. 1988 Dec;7(3):325–337. doi: 10.1016/s0168-8278(88)80005-9. [DOI] [PubMed] [Google Scholar]
  33. Wang L., Hasegawa T., Nadai M., Muraoka I., Nabeshima T., Kato N. The effect of lipopolysaccharide on the disposition of xanthines in rats. J Pharm Pharmacol. 1993 Jan;45(1):34–38. doi: 10.1111/j.2042-7158.1993.tb03675.x. [DOI] [PubMed] [Google Scholar]
  34. Watkins J. B., 3rd, Dykstra T. P. Alterations in biliary excretory function by streptozotocin-induced diabetes. Drug Metab Dispos. 1987 Mar-Apr;15(2):177–183. [PubMed] [Google Scholar]
  35. Watkins J. B., 3rd, Noda H. Biliary excretion of organic anions in diabetic rats. J Pharmacol Exp Ther. 1986 Nov;239(2):467–473. [PubMed] [Google Scholar]
  36. Yamaguchi Y., Yamaguchi K., Babb J. L., Gans H. In vivo quantitation of the rat liver's ability to eliminate endotoxin from portal vein blood. J Reticuloendothel Soc. 1982 Dec;32(6):409–422. [PubMed] [Google Scholar]
  37. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn. 1981 Nov;4(11):879–885. doi: 10.1248/bpb1978.4.879. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES